… ProQR to Present at Two Upcoming Investor Conferences in … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Financial Results for the Second Quarter of … progress towards accomplishing the goals set out in ProQR’s Vision 2023 strategy, which includes starting the … property costs and other allocated costs. The increase in R&D expenses was primarily due to initiation of the clinical …
ProQR Therapeutics today announced virtual poster presentations at the Annual Meeting of the American Academy of Ophthalmology (AAO) held November 13-15, 2020.
LEIDEN, the Netherlands and CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced
… ProQR Announces Expert Perspectives Call on LCA10 and … & CAMBRIDGE, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … presentation by Aniz Girach, MD, Chief Medical Officer of ProQR Therapeutics. Dr. Girach will then discuss the …
… ProQR Prices $75 Million Underwritten Public Offering and … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through … and commissions and other offering expenses payable by ProQR. All of the shares are being offered by ProQR. In …